Evaluation of abnormal liver tests

Medical Clinics of North America

Volumn 98, Issue 1, 2014, Pages 1-16

  Woreta, Tinsay A ^a   Alqahtani, Saleh A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Alkaline phosphatase; Aminotransferases; Bilirubin metabolism; Cholestasis; Hepatocellular injury

Indexed keywords

5' NUCLEOTIDASE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; PARACETAMOL;

ALCOHOL LIVER DISEASE; AMANITA PHALLOIDES; AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; CLINICAL EVALUATION; COMMON BILE DUCT STONE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; EPSTEIN BARR VIRUS INFECTION; EXTRAHEPATIC BILE DUCT OBSTRUCTION; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HERPES ZOSTER; INTOXICATION; ISCHEMIC HEPATITIS; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER METABOLISM; MIXED INFECTION; NON INVASIVE PROCEDURE; PANCREAS CANCER; PHYSICAL EXAMINATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPSIS; SYNTHESIS; TOXIC HEPATITIS;

ALKALINE PHOSPHATASE; AMINOTRANSFERASES; BILIRUBIN METABOLISM; CHOLESTASIS; HEPATOCELLULAR INJURY;

ALKALINE PHOSPHATASE; BILIRUBIN; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HEPATOCYTES; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; PROGNOSIS; PROTHROMBIN; SERUM ALBUMIN; TRANSAMINASES;

EID: 84888053035     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.09.005     Document Type: Review

References (24)

1. Green R.M., Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002, 123(4):1367-1384.
2. Franklin Herlong F.H., Mitchell M.C. Laboratory tests. Schiff's diseases of the liver 2012, 17-43. Wiley-Blackwell. W.C. Maddrey, E.R. Schiff, M.F. Sorrell (Eds.).
3. Mukherjee S., Gollan J.L. Assessment of liver function. Sherlock's diseases of the liver and biliary system 2011, 20-35. Wiley-Blackwell. A.S. Lok, J.S. Dooley, A.K. Burroughs (Eds.).
4. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. NEngl J Med 2000, 342(17):1266-1271.
5. Piton A., et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998, 27(5):1213-1219.
6. Floch M.H., Floch N.R., Kowdley K.V., et al. Netter's gastroenterology. 1st edition 2005, 900. Icon Learning Systems, Carlstadt (NJ).
7. Longo D.L., et al. Harrison's gastroenterology and hepatology 2010, 738. McGraw-Hill Medical, New York.
8. Cohen J.A., Kaplan M.M. The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig Dis Sci 1979, 24(11):835-838.
9. Diehl A.M., et al. Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984, 86(4):632-636.
10. Bamford K.F., et al. Serum-alkaline-phosphatase and the ABO blood-groups. Lancet 1965, 1(7384):530-531.
11. Heino A.E., Jokipii S.G. Serum alkaline phosphatase levels in the aged. Ann Med Intern Fenn 1962, 51:105-109.
12. Sotil E.U., Jensen D.M. Serum enzymes associated with cholestasis. Clin Liver Dis 2004, 8(1):41-54.
13. Goldberg D.M., Martin J.V. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975, 12(4-6):232-246.
14. Rollason J.G., Pincherle G., Robinson D. Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta 1972, 39(1):75-80.
15. Righetti A., Kaplan M.M. Disparate responses of serum and hepatic alkaline phosphatase and 5' nucleotidase to bile duct obstruction in the rat. Gastroenterology 1972, 62(5):1034-1039.
16. Lester R., Schmid R. Bilirubin metabolism. NEngl J Med 1964, 270:779-786.
17. Robinson S.H., et al. Early-labeled peak of bile pigment in man. Studies with glycine-14C and delta-aminolevulinic acid-3H. NEngl J Med 1967, 277(25):1323-1329.
18. Zieve L., et al. Normal and abnormal variations and clinical significance of the one-minute and total serum bilirubin determinations. JLab Clin Med 1951, 38(3):446-469.
19. Weiss J.S., et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. NEngl J Med 1983, 309(3):147-150.
20. American Gastroenterological Association American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. Gastroenterology 2002, 123(4):1364-1366.
21. Polson J., Lee W.M., American Association for the Study of Liver AASLD position paper: the management of acute liver failure. Hepatology 2005, 41(5):1179-1197.
22. Miyake T., et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 2012, 56(4):1271-1278.
23. Berzigotti A., et al. Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension. Dis Markers 2011, 31(3):129-138.
24. Crespo G., Fernández-Varo G., Mariño Z., et al. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. JHepatol 2012, 57(2):281.